Literature DB >> 3926372

Recombinant DNA and other direct specimen identification techniques.

L S Tompkins.   

Abstract

DNA molecules and monoclonal antibodies can now be employed in the clinical laboratory to detect microorganisms in clinical samples. DNA probes are produced by cloning specific gene sequences which then react with homologous target DNA in the sample by DNA hybridization. Monoclonal antibodies are also produced by selection, cloning, and tagging, much like DNA probes. Both methods appear to be highly sensitive, specific, and rapid in the detection of microorganisms.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3926372

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  5 in total

1.  DNA probes for clinical applications. Patents and literature.

Authors:  R J Linhardt
Journal:  Appl Biochem Biotechnol       Date:  1986-06       Impact factor: 2.926

2.  Use of synthetic oligonucleotide DNA probes for the identification of Bacteroides gingivalis.

Authors:  B J Moncla; P Braham; K Dix; S Watanabe; D Schwartz
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

3.  Use of synthetic oligonucleotide DNA probes for identification and direct detection of Bacteroides forsythus in plaque samples.

Authors:  B J Moncla; S T Motley; P Braham; L Ewing; T H Adams; N M Vermeulen
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

4.  A Candida albicans dispersed, repeated gene family and its epidemiologic applications.

Authors:  S Scherer; D A Stevens
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

5.  Comparative evaluation of AccuProbe culture identification test for Neisseria gonorrhoeae and other rapid methods.

Authors:  H Young; A Moyes
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.